Yuwell 8F
Key features
- Purity 90-95%
- Type Home Stationary
- Continuous Flow 0.5-5LPM
- Weight 15.5kg
- Oxygen Purity Indicator (OPI) No
- Power consumption 400watts
Specifications
| Purity | 90-95% |
|---|---|
| Type | Home Stationary |
| Continuous Flow | 0.5-5LPM |
| Weight | 15.5kg |
| Power consumption | 400watts |
| Sound level | 52db |
| Dimensions | 24.5H x 19.6W x 15.3Dinch |
| Outlet pressure | 10psi |
| Loss of Power Alarm | Yes |
|---|---|
| System Malfunction Alarm | Yes |
| Indian Voltage Model | Yes |
| Company Headquarters | China |
Pros and cons
PROS
- Street price often ₹20,000 against a ₹43,200 MRP — the best rupees-per-LPM deal in the Yuwell lineup
- 15.5 kg weight is the lightest Yuwell stationary 5 LPM — tractable for a single person
- Integrated nebulizer port useful for patients on nebulised bronchodilators
- Real Indian user history with a 4.3/5 aggregate on the source listing (22 reviews)
- Yuwell-authorised service paths in metros are still active for this SKU
CONS
- No oxygen purity indicator (OPI) on the front panel
- 52 dB noise floor is 7–12 dB higher than Tier-1 peers (Everflo 45, Nidek 40)
- 400 W power draw is 40 % higher than a Nidek Nuvo Lite
- Brochure leaves FDA, FAA and CE fields blank
- No published altitude rating on the Indian spec sheet
The 8F is where Yuwell’s Indian offer actually makes sense
Of all the Yuwell concentrators in this review cycle, the 8F is the one HHZ would still recommend for a specific buyer — the household on a ₹20,000–25,000 budget who needs a working 5 LPM concentrator now, with a nebulizer built in, from a brand with a metro-city service path. The 8F is lighter than the 7F, quieter than the 9F, has an integrated nebulizer port, and is priced on most Indian listings at or near ₹20,000 against a list MRP of ₹43,200. That price-to-spec combination is the strongest Yuwell case in the current market. The manufacturer brochure and e-commerce product listings HHZ referenced show a 4.3/5 rating across 22 buyer reviews, which is consistent with the unit’s “does the job, does not surprise you” reputation in Indian hospital-supply circuits.
That is not the same as saying the 8F is the best 5 LPM concentrator available in India. It is not. The Philips Everflo and Nidek Nuvo Lite are better machines. The Oxymed Mini is the better Indian-brand alternative. The BPL Oxy 5 Neo has a better service network. But if your budget caps at ₹25,000, all of those alternatives are out of reach, and the choice reduces to which Chinese OEM 5 LPM you prefer. Among that cohort the 8F has the most credible brand, the most reviews, and a feature — the nebulizer — that many of its competitors do not offer.
What the specs actually mean
Continuous flow 0.5–5 LPM, purity 90–95 %. Standard Chinese PSA zeolite spec. The brochure does not publish a per-flow purity table. Expect 95 % at 2–3 LPM, 90 % at the top of the range. Adequate for the typical 1–3 LPM prescription. Without an OPI light on the front you cannot verify this in service, which is the 8F’s biggest clinical gap relative to Tier-1 alternatives.
Weight 15.5 kg. This is the spec that distinguishes the 8F from the 7F and most other Chinese OEM 5 LPMs. 15.5 kg is 2 kg heavier than a Nidek Nuvo Lite (13.6) and 1.5 kg heavier than a Philips Everflo (14). It is 11.5 kg lighter than the 7F and 3.5 kg lighter than the 9F. An adult in reasonable health can lift 15.5 kg with two hands. The chassis does not have a published top handle in Yuwell’s brochure imagery, which is a persistent Yuwell design quibble — if you plan to carry the unit room-to-room daily, confirm the specific SKU ships with a handle.
Power 400 W. 400 W is not the best number in the class — a Nidek runs at 290 W, an Everflo at 350 W, an Oxymed Mini at 390 W. But it is 100 W less than the 7F’s 500 W draw, which is meaningful. At 16-hour-a-day LTOT and ₹7/unit that 100 W saving is roughly ₹150 a month, ₹5,400 over three years — enough to matter but not transformative.
Noise 52 dB. Same as the 9F, 1 dB better than the 7F. Audible in a bedroom. Quieter than a BPL Oxy 5 Neo (55 dB) but noisier than any Tier-1 5 LPM. For a patient who sleeps with the concentrator running, 52 dB is the spec that will drive post-purchase regret unless the unit is placed outside the bedroom.
Integrated nebulizer. This is the feature that earns the 8F its “with Nebulizer” trim designation. Indian patients with concurrent asthma or COPD requiring bronchodilator nebulisation often buy a separate nebulizer machine on top of their concentrator. The 8F bundles the function. For a buyer who would otherwise spend ₹2,500–4,000 on a separate nebulizer that is a genuine value add. The clinical quality of the built-in nebulizer is not verified — it is a standard compressor-fed reservoir — but for bronchodilator delivery at home the engineering bar is low.
Certifications: blank. FDA, FAA and CE fields on the Indian brochure are empty for this SKU. Yuwell holds CE marks in other markets on other models; the specific 8F Indian SKU does not publish a certification claim. Treat as uncertified unless the importer can provide written documentation per batch.
Dimensions 24.5 × 19.6 × 15.3 inches (H×W×D). Box in the 8F size class, vertical orientation.
Who should buy it
Budget-capped households with a 6–24 month oxygen therapy window. If the prescription is for post-discharge recovery, a rehab phase, or a chronic condition where the budget caps at ₹25,000 and the patient also benefits from nebulised medication, the 8F’s street price and integrated nebulizer make it the best deployment of that rupee budget among Chinese OEMs.
Households that specifically want a Yuwell. Some Indian buyers prefer Chinese brands with recognisable names (Yuwell, Omron, Haier) to Indian brands they have not heard of. If that is your bias, the 8F is the Yuwell to pick. It is lighter and quieter than the 7F, and cheaper and simpler than the 9F’s touchscreen.
Backup-unit buyers. For households where a Philips, Nidek or Oxymed is the primary, the 8F is a reasonable secondary — different brand diversifies spares risk, nebulizer function is useful, cost is low.
Patients with concurrent bronchodilator therapy. The integrated nebulizer is a real workflow simplification for asthma/COPD patients who also need occasional salbutamol or ipratropium delivery. One device on the bedside instead of two.
Who should not buy it
LTOT patients on 15+ hours/day for 3+ years. The 8F will work but it is the wrong economic choice. The electricity gap versus a Nidek (110 W lower) plus the uncertain certification status argues for the Nidek at ₹57,000 over three years of use.
Patients titrated below 0.5 LPM or needing precise low-flow control. The 8F does 0.5–5 LPM in ball-flowmeter increments. A Nidek Nuvo Lite goes to 0.125 LPM with 12 flow settings. For pediatric or precisely titrated adult therapy the Nidek is the answer.
Buyers outside Yuwell-service metro cities. Remote users should prefer a brand with wider Indian service footprint — BPL or Oxymed — over Yuwell.
Users who need FDA/CE documentation for insurance or NRI resale. The 8F does not publish those certifications on the Indian brochure.
Alternatives that beat the 8F on specific axes
Philips Respironics EverFlo, ~₹43,700–50,000 street. Every spec the 8F has, the Everflo has better: 14 kg versus 15.5, 350 W versus 400, 45 dB versus 52, FDA-approved, CE-marked, OPI present, 3-year Indian warranty. The Everflo has no integrated nebulizer but you can add a standalone nebulizer for ₹3,000 and still come out cheaper over three years on electricity alone. If the budget stretches to ₹45,000, the Everflo is the correct answer.
Oxymed Mini 5 LPM, ~₹35,000–45,000 street. The Indian-made Mini is 13.9 kg, 390 W, 45 dB, has an OPI with a digital purity analyser, and supports 3-year warranty through Oxymed’s roughly 50-city Indian service network. Against the 8F it wins on weight, noise, purity indication and domestic service. The 8F’s one advantage is price and, arguably, the integrated nebulizer. At ₹35,000+ versus the 8F’s ₹20,000 the choice is budget-driven; at parity the Oxymed is the better machine.
BPL Oxy 5 Neo, ~₹32,000 street. Heavier (25 kg) and louder (55 dB) than the 8F, but has an OPI, is Indian-branded with a pan-India service network, and comes with BPL’s two-year warranty. For users in Tier-2/Tier-3 cities who value service access over raw specs the BPL is the right call. For urban buyers where Yuwell’s metro service works the 8F is cheaper and lighter.
Indian-market considerations
The 8F is one of the Yuwell SKUs that benefits most from the brand’s lingering Indian retail presence. It is carried by enough dealers that you can find a service path in every metro and in most Tier-2 cities through the importer’s network. Warranty claim cycle times are typically 2–4 weeks for a sieve-bed or compressor issue — not fast by Tier-1 standards (Philips runs 1–2 weeks typical in metros) but acceptable.
Spare-parts availability for the 8F is the best of the Yuwell family because it remains in active production. Sieve beds, compressors and valve blocks are cross-compatible with several other Chinese OEM 5 LPM platforms (Niscomed, Konsung, Keyhub), which means independent biomed shops can service the unit even if the authorised importer is slow. Compressor replacement costs in Indian service centres run ₹6,000–10,000; sieve-bed service ₹4,000–7,000.
CDSCO MD-14 import licensing under the 2022 framework applies to all Class B oxygen concentrator imports. Before purchase, ask the seller for the importer’s MD-14 number and the specific import batch the unit belongs to. A legitimate authorised Yuwell dealer will have this information on file; a small reseller operating on marketplace platforms may not. (CDSCO)
The 8F’s nebulizer function is one of the genuine Indian-market adaptations — asthma and COPD overlap in the Indian 5 LPM buyer population is high, and a combined device simplifies the bedside. Filter replacement on the nebulizer circuit is a separate consumables cost; budget ₹300–500 a year for mouthpieces, cups and tubing.
Out-of-warranty total cost of ownership on a 3-year horizon for the 8F is roughly: one sieve-bed service (₹5,000), one capacitor or valve replacement (₹2,000–3,000), two air-intake filter changes (₹600 total), and electricity at 16 hrs/day (~₹65,000–80,000 depending on state tariff). Against a purchase price of ₹20,000 the total three-year cost is in the ₹95,000–110,000 range — not materially different from running a Tier-1 at ₹45,000–57,000 purchase + lower electricity.
Verdict
The Yuwell 8F is the only Yuwell in this review cycle HHZ can recommend without heavy caveats for a typical Indian buyer, and even then only conditionally. At its ₹20,000 street price it is the best value-per-specification in the Yuwell lineup, the integrated nebulizer is genuinely useful for the common Indian asthma/COPD/LTOT overlap case, and Yuwell’s metro-city service still works for this SKU. Against a Tier-1 like the Philips Everflo it loses on weight, noise, power and certifications. Against the Indian-made Oxymed Mini it loses on service breadth and purity indication. Against the BPL Oxy 5 Neo it wins on weight and price. For a sub-₹25,000 budget where nebulization and a recognised name matter, the 8F is the right buy. For any budget above ₹35,000, pick one of the alternatives.
